The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
It Feels Like It’s Time to Short Chipotle, But …
The popular restaurant chain is outrageously overvalued, but shorting is dangerous. Investors are safer playing options on CMG instead. More
South Korea: Look North … and West
Korea is a reunification story still waiting to be told -- and it's one with substantial, but nebulous, long-term potential. More
Utilities Burn Bright as Market Outlook Dims
An improving U.S. economy and the coldest March in recent memory have the utility sector putting up electrifying returns so far this year. Their defensive nature will help maintain that run in months ahead. More
Samsung Experience: It’s Great … Just Not for Best Buy
Samsung has announced plans to open 'Samsung Experience' mini-shops within Best Buy, but the benefits seem pretty one-sided. More
‘Smart Money’ Still Chasing Blue Chips, but Should You?
Investors should stay on the sidelines, preserving their buying power until after the current indecision runs its course. More
Acquire This Biotech Takeover Target ASAP
Life Technologies is rumored to be looking for a buyer, and the stock is poised for a breakout. More
